July/August 2024

Featured Article

From the Field

Bridging the Gap Between Oncologists and Payers: Impact of an EHR-Embedded CDS Tool in Oncology Clinical Pathway (OCP) Adherence

08/15/2024

Anna Bolha , MPAS, PA;

Rebecca Maniago , PharmD, BCOP;

Nina Sardesh ;

Taylor Dias-Foundas ;

James Roose , MA;

Colin Harvey ;

Marcello Ricottone ;

Eric Weber ;

Susan Sabo-Wagner , MSN, RN, OCN, NEA-BC;

Brian Patrick Mulherin , MD;

Andrew Hertler , MD, FACP;

James Hamrick , MD, MPH;

In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...

In this report, researchers...

08/15/2024

Journal of Clinical Pathways

Perspectives

Individualized Care Through Treatment Pathways: Isn’t This an Oxymoron?

06/26/2024

Ray Page , DO, PhD, FACOI, FASCO;

This article describes how congruent solutions for treatment options can be achieved if the objectives of precision medicine and treatment pathways are aligned.

This article describes how...

06/26/2024

Journal of Clinical Pathways

Feature

Research Reports

Time to Treatment and the “Golden Hour”: Why They Matter and How Clinical Pathways Can Help

08/19/2024

Dennis R. Holmes , MD, FACS;

Juvairiya Pulicharam , MD;

Steven Evans , MD;

This study explores how clinical pathways can help reduce time to treatment delays while improving health care quality, lowering direct and indirect health care costs, reducing patient financial toxicity, and achieving greater patient,...

This study explores how clinical...

08/19/2024

Journal of Clinical Pathways

Column

Transformative Employer Trends

Pharmacy and Therapeutics, Formulary Committees, and Clinical Pathways: Has Anything Changed Since 2004?

08/12/2024

F. Randy Vogenberg , PhD, FASHP;

This column discusses how new and increasingly expensive therapies in the health care industry marketplace continues to cause providers, patients, and payers financial burden and how new strategies are needed to effectively manage them.

This column discusses how new...

08/12/2024

Journal of Clinical Pathways

MAI Mindset

Pathways Are Now a Popular Tool for Organizations Delivering Cancer Care

08/09/2024

Lee Blansett , MBA;

Cindy Chen , MBA;

Emma Bijesse , MBA;

This entry of our MAI Mindset column focuses on provider-implemented pathways in provider organizations and their association with other internal structures and processes within a wide range of organizations providing treatment to patients...

This entry of our MAI Mindset...

08/09/2024

Journal of Clinical Pathways

Editor's Page

Balancing Cost, Efficiency, and Clinical Judgment In Advancing Value-Based Care

08/07/2024

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including a review of tools, pathways strategies, and outcomes to promote value-based care and implement clinical pathways.

Editor-in-Chief Winston Wong,...

08/07/2024

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

July/August 2024

Featured Article

Feature

Column

Current Issue

Special Reports

Subscribe

August 2024 Volume 10 Issue 4

Specialties

Events

Year Round Education

HMP Global Products